1995
DOI: 10.1016/0024-3205(95)00281-a
|View full text |Cite
|
Sign up to set email alerts
|

Effects of acute and chronic estrogenic treatment on vasomotor responses of aortic rings from ovariectomized rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
26
2

Year Published

1996
1996
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 35 publications
(30 citation statements)
references
References 28 publications
2
26
2
Order By: Relevance
“…This finding is in accordance with previous "ex vivo" studies showing that long-term replacement of estrogen significantly blunted the adrenergic sensitivity of mesenteric arteries (6, 7) and aortic rings (8). In their studies, NO synthase inhibition reverted or lessened the attenuating effect of estrogen on the adrenergic vasoconstrictor responses, suggesting that basal NO release is a major determinant of this phenomenon.…”
Section: Discussionsupporting
confidence: 92%
See 2 more Smart Citations
“…This finding is in accordance with previous "ex vivo" studies showing that long-term replacement of estrogen significantly blunted the adrenergic sensitivity of mesenteric arteries (6, 7) and aortic rings (8). In their studies, NO synthase inhibition reverted or lessened the attenuating effect of estrogen on the adrenergic vasoconstrictor responses, suggesting that basal NO release is a major determinant of this phenomenon.…”
Section: Discussionsupporting
confidence: 92%
“…Thus the doses of EV 5 µg and 25 µg used in the present study might have exerted 2.5 and 12.5 times more potent action than the dose used for hormone replacement, respectively. Paredes-Carbajal et al (8) have shown that the contractile responses to phenylephrine in aortic rings excised from OVX rats are not altered before or after (40-60 min) addition of a physiological level of 17β-estradiol (10 9 mol/l), while chronic (11-13 days) treatment with a physiological level of estrogen significantly attenuated the adrenergic vasoconstriction. They speculated that acute administration of estrogen does not increase basal NO release enough to attenuate the adrenergic vasoconstriction, because it takes at least several days for estrogen to increase eNOS mRNA and eNOS activity (21,22).…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…In previous studies, we demonstrated that the vasorelaxant effects of BcEx are mediated by enhancement of the NO/cGMP system and inhibition of calcium influx into vascular smooth muscle cells [13]. Additionally, carbachol elicits endothelium-dependent, NO-mediated relaxation in isolated rat aortae [29]. In our study, the vasomotor response to carbachol in isolated aortas contracted by NE was reduced in OVX-control rats compared with sham-control rats.…”
Section: Discussionsupporting
confidence: 49%
“…Notably, short-term hydrocortisone exposure mediated an enhancement of vasoconstrictor response-consistent with the findings of others. 26,27 17␤-Estradiol has previously been demonstrated to "nongenomically" enhance vasorelaxation and attenuate vasoconstriction, 28,29 ie, effects comparable to those of aldosterone. However, these previously reported effects of estradiol were seen at much higher concentrations (nmol/L to mol/L) than those used in the present studies.…”
Section: Discussionmentioning
confidence: 99%